1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Peptide Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Innovative
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Manufacturer
7.1 Outsourced
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 In-house
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Synthesis Technology
8.1 Solid Phase Peptide Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hybrid Technology
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Routes of Administration
9.1 Parenteral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Application
10.1 Gastrointestinal Disorders
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurological Disorders
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Metabolic Disorders
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Cancer
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Amgen Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Apitope International NV
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Arch Biopartners Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 AstraZeneca plc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Circle Pharma Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Corden Pharma GmbH
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Ipsen Group
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Lonza Group AG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novo Nordisk A/S
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pfizer Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Teva Pharmaceuticals Industries Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Zealand Pharma A/S
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
List of Figures
Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion USD), 2018-2023
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion USD), 2024-2032
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2023
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2023
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2023
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2023
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2023
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2023
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million USD), 2018 & 2023
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million USD), 2018 & 2023
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million USD), 2018 & 2023
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million USD), 2018 & 2023
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million USD), 2018 & 2023
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million USD), 2018 & 2023
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million USD), 2018 & 2023
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2018 & 2023
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million USD), 2018 & 2023
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million USD), 2018 & 2023
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million USD), 2018 & 2023
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million USD), 2018 & 2023
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million USD), 2018 & 2023
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million USD), 2018 & 2023
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2018 & 2023
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million USD), 2018 & 2023
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2023
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million USD), 2024-2032
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million USD), 2024-2032
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million USD), 2024-2032
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million USD), 2024-2032
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million USD), 2024-2032
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million USD), 2024-2032
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players